EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Persistent response to combination treatment of pemigatinib and chemotherapy in a patient with advanced gastric cancer: A case report

Jing Wu, Yuehong Cui, Shan Yu

Malignancy Spectrum · 2024

DOI: 10.1002/msp2.39 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Malignancy Spectrum, 2024. Verfasst von Jing Wu und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study aimed to report the treatment and outcomes of a patient with advanced gastric cancer (GC) using a combination of a targeted molecular therapy and chemotherapy. Patients and methods A 40‐year‐old woman presented with abdominal metastatic nodules and peritoneal effusion. Biopsy and cytology identified signet ring cell carcinoma. Ten months after the onset of initial symptoms, gastroscopy confirmed signet ring cell carcinoma of the gastric body. Genetic testing revealed amplification of the fibroblast growth factor receptor ( FGFR ) gene. Consequently, the patient received FGFR inhibitor pemigatinib in addition to a chemotherapy regimen of albumin paclitaxel plus 5‐fluorouracil.

Results

During the treatment, the patient experienced recurrent liver function abnormalities and intestinal obstruction, which were managed with symptom‐specific medications and supportive therapies. The combined treatment regimen resulted in a progression‐free survival (PFS) period of ten months.

Conclusion

The integration of FGFR inhibitor pemigatinib with standard chemotherapy showed promising results in prolonging PFS in a patient with advanced GC characterized by FGFR gene amplification, despite the occurrence of manageable side effects.

Zitieren

APA

Wu, J., Cui, Y., & Yu, S. (2024). Persistent response to combination treatment of pemigatinib and chemotherapy in a patient with advanced gastric cancer: A case report. Malignancy Spectrum. https://doi.org/10.1002/msp2.39

Vancouver

Wu J, Cui Y, Yu S. Persistent response to combination treatment of pemigatinib and chemotherapy in a patient with advanced gastric cancer: A case report. Malignancy Spectrum. 2024. doi:10.1002/msp2.39

BibTeX
@article{Wu2024,
  author = {Wu, Jing and Cui, Yuehong and Yu, Shan},
  title = {Persistent response to combination treatment of pemigatinib and chemotherapy in a patient with advanced gastric cancer: A case report},
  journal = {Malignancy Spectrum},
  year = {2024},
  doi = {10.1002/msp2.39}
}
Kostenlos starten →